RACHEL GARRISON: Open Payments
NPI 1033624523 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$972 in 62 payments from 22 companies in 2025. Trend: 2023 $933 · 2024 $671 · 2025 $972
Food & beverage: $972
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $162 |
| Teva Pharmaceuticals USA, Inc. | 7 | $150 |
| AstraZeneca Pharmaceuticals LP | 6 | $112 |
| Abbott Laboratories | 5 | $87 |
| Amgen Inc. | 4 | $68 |
| PFIZER INC. | 3 | $49 |
| ABBVIE INC. | 3 | $47 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| Lilly USA, LLC | 2 | $39 |
| Antares Pharma, Inc. | 1 | $24 |
Products named: AUSTEDO XR, FREESTYLE LIBRE 3, Wegovy, Ozempic, AIRSUPRA, NURTEC ODT, OTEZLA, FARXIGA.
Industry payments across OK — which companies pay providers there.
